Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component) (ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6) (CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component) (Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component) (DRIP80)

 MED17_HUMAN             Reviewed;         651 AA.
Q9NVC6; B3KN07; Q9HA81; Q9UNP7; Q9Y2W0; Q9Y660;
28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
18-MAY-2010, sequence version 2.
20-JUN-2018, entry version 149.
RecName: Full=Mediator of RNA polymerase II transcription subunit 17;
AltName: Full=Activator-recruited cofactor 77 kDa component;
Short=ARC77;
AltName: Full=Cofactor required for Sp1 transcriptional activation subunit 6;
Short=CRSP complex subunit 6;
AltName: Full=Mediator complex subunit 17;
AltName: Full=Thyroid hormone receptor-associated protein complex 80 kDa component;
Short=Trap80;
AltName: Full=Transcriptional coactivator CRSP77;
AltName: Full=Vitamin D3 receptor-interacting protein complex 80 kDa component;
Short=DRIP80;
Name=MED17; Synonyms=ARC77, CRSP6, DRIP77, DRIP80, TRAP80;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 306-319;
405-415 AND 592-602, TISSUE SPECIFICITY, IDENTIFICATION IN TRAP
COMPLEX, AND VARIANT ASP-69.
TISSUE=Cervix carcinoma;
PubMed=10198638; DOI=10.1016/S1097-2765(00)80463-3;
Ito M., Yuan C.-X., Malik S., Gu W., Fondell J.D., Yamamura S.,
Fu Z.-Y., Zhang X., Qin J., Roeder R.G.;
"Identity between TRAP and SMCC complexes indicates novel pathways for
the function of nuclear receptors and diverse mammalian activators.";
Mol. Cell 3:361-370(1999).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 88-99 AND
607-619, IDENTIFICATION IN ARC COMPLEX, AND VARIANT ASP-69.
TISSUE=Cervix carcinoma;
PubMed=10235266; DOI=10.1038/19783;
Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M.,
Naeaer A.M., Erdjument-Bromage H., Tempst P., Freedman L.P.;
"Ligand-dependent transcription activation by nuclear receptors
requires the DRIP complex.";
Nature 398:824-828(1999).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
ASP-69.
TISSUE=Embryo;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16554811; DOI=10.1038/nature04632;
Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
Sakaki Y.;
"Human chromosome 11 DNA sequence and analysis including novel gene
identification.";
Nature 440:497-500(2006).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
ASP-69.
TISSUE=Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [MRNA] OF 269-651 (ISOFORM 1).
PubMed=9989412; DOI=10.1038/17141;
Ryu S., Zhou S., Ladurner A.G., Tjian R.;
"The transcriptional cofactor complex CRSP is required for activity of
the enhancer-binding protein Sp1.";
Nature 397:446-450(1999).
[7]
IDENTIFICATION IN ARC COMPLEX, AND PROTEIN SEQUENCE OF 168-179 AND
355-361.
PubMed=10235267; DOI=10.1038/19789;
Naeaer A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W.B.,
Tjian R.;
"Composite co-activator ARC mediates chromatin-directed
transcriptional activation.";
Nature 398:828-832(1999).
[8]
INTERACTION WITH MED10.
PubMed=12584197; DOI=10.1074/jbc.C300054200;
Sato S., Tomomori-Sato C., Banks C.A.S., Sorokina I., Parmely T.J.,
Kong S.E., Jin J., Cai Y., Lane W.S., Brower C.S., Conaway R.C.,
Conaway J.W.;
"Identification of mammalian Mediator subunits with similarities to
yeast Mediator subunits Srb5, Srb6, Med11, and Rox3.";
J. Biol. Chem. 278:15123-15127(2003).
[9]
INTERACTION WITH STAT2.
PubMed=12509459; DOI=10.1128/MCB.23.2.620-628.2003;
Lau J.F., Nusinzon I., Burakov D., Freedman L.P., Horvath C.M.;
"Role of metazoan mediator proteins in interferon-responsive
transcription.";
Mol. Cell. Biol. 23:620-628(2003).
[10]
IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
MEDIATOR COMPLEX.
PubMed=15175163; DOI=10.1016/j.molcel.2004.05.006;
Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B.,
Swanson S.K., Banks C.A.S., Jin J., Cai Y., Washburn M.P.,
Conaway J.W., Conaway R.C.;
"A set of consensus mammalian mediator subunits identified by
multidimensional protein identification technology.";
Mol. Cell 14:685-691(2004).
[11]
INTERACTION WITH MED1; MED10; MED18; MED21; MED28 AND MED30,
IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE MEDIATOR
COMPLEX, AND ASSOCIATION OF THE MEDIATOR COMPLEX WITH RNA POLYMERASE
II.
PubMed=15989967; DOI=10.1016/j.molcel.2005.05.015;
Zhang X., Krutchinsky A., Fukuda A., Chen W., Yamamura S., Chait B.T.,
Roeder R.G.;
"MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation
enriched in RNA polymerase II and is required for ER-mediated
transcription.";
Mol. Cell 19:89-100(2005).
[12]
FUNCTION, AND INTERACTION WITH MED1 AND MED10.
PubMed=16595664; DOI=10.1074/jbc.M601983200;
Baek H.J., Kang Y.K., Roeder R.G.;
"Human Mediator enhances basal transcription by facilitating
recruitment of transcription factor IIB during preinitiation complex
assembly.";
J. Biol. Chem. 281:15172-15181(2006).
[13]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Embryonic kidney;
PubMed=17525332; DOI=10.1126/science.1140321;
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
"ATM and ATR substrate analysis reveals extensive protein networks
responsive to DNA damage.";
Science 316:1160-1166(2007).
[14]
VARIANT [LARGE SCALE ANALYSIS] ASP-69, AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[15]
VARIANT [LARGE SCALE ANALYSIS] ASP-69, AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
Mann M., Daub H.;
"Large-scale proteomics analysis of the human kinome.";
Mol. Cell. Proteomics 8:1751-1764(2009).
[16]
VARIANT MCPHSBA PRO-371.
PubMed=20950787; DOI=10.1016/j.ajhg.2010.09.016;
Kaufmann R., Straussberg R., Mandel H., Fattal-Valevski A.,
Ben-Zeev B., Naamati A., Shaag A., Zenvirt S., Konen O.,
Mimouni-Bloch A., Dobyns W.B., Edvardson S., Pines O., Elpeleg O.;
"Infantile cerebral and cerebellar atrophy is associated with a
mutation in the MED17 subunit of the transcription preinitiation
mediator complex.";
Am. J. Hum. Genet. 87:667-670(2010).
-!- FUNCTION: Component of the Mediator complex, a coactivator
involved in the regulated transcription of nearly all RNA
polymerase II-dependent genes. Mediator functions as a bridge to
convey information from gene-specific regulatory proteins to the
basal RNA polymerase II transcription machinery. Mediator is
recruited to promoters by direct interactions with regulatory
proteins and serves as a scaffold for the assembly of a functional
preinitiation complex with RNA polymerase II and the general
transcription factors. {ECO:0000269|PubMed:16595664}.
-!- SUBUNIT: Interacts with GATA1 and PPARG (By similarity). Component
of the Mediator complex, which is composed of MED1, MED4, MED6,
MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14,
MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23,
MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and
CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a
distinct module termed the CDK8 module. Mediator containing the
CDK8 module is less active than Mediator lacking this module in
supporting transcriptional activation. Individual preparations of
the Mediator complex lacking one or more distinct subunits have
been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP.
Interacts with STAT2. {ECO:0000250, ECO:0000269|PubMed:10198638,
ECO:0000269|PubMed:10235266, ECO:0000269|PubMed:10235267,
ECO:0000269|PubMed:12509459, ECO:0000269|PubMed:12584197,
ECO:0000269|PubMed:15175163, ECO:0000269|PubMed:15989967,
ECO:0000269|PubMed:16595664}.
-!- INTERACTION:
Q9D8C6:Med11 (xeno); NbExp=2; IntAct=EBI-394562, EBI-6260909;
Q15528:MED22; NbExp=3; IntAct=EBI-394562, EBI-394687;
Q6P2C8:MED27; NbExp=2; IntAct=EBI-394562, EBI-394603;
Q9CQI9:Med30 (xeno); NbExp=2; IntAct=EBI-394562, EBI-309220;
O75586:MED6; NbExp=2; IntAct=EBI-394562, EBI-394624;
Q9D7W5:Med8 (xeno); NbExp=2; IntAct=EBI-394562, EBI-7990252;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q9NVC6-1; Sequence=Displayed;
Name=2;
IsoId=Q9NVC6-2; Sequence=VSP_028115, VSP_028116;
Note=May be due to intron retention.;
-!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10198638}.
-!- DISEASE: Microcephaly, postnatal progressive, with seizures and
brain atrophy (MCPHSBA) [MIM:613668]: A disorder characterized by
postnatal progressive microcephaly and severe developmental
retardation associated with cerebral and cerebellar atrophy.
Infants manifest swallowing difficulties leading to failure to
thrive, jitteriness, poor visual fixation, truncal arching,
seizures. There is no acquisition of developmental milestones and
patients suffer from marked spasticity and profound retardation.
Progressive microcephaly becomes evident few months after birth.
{ECO:0000269|PubMed:20950787}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the Mediator complex subunit 17 family.
{ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAD30856.1; Type=Frameshift; Positions=333, 335, 341, 346; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF117657; AAD22031.2; -; mRNA.
EMBL; AF105421; AAD30856.1; ALT_FRAME; mRNA.
EMBL; AK001674; BAA91827.1; -; mRNA.
EMBL; AK022156; BAB13973.1; -; mRNA.
EMBL; AK023209; BAG51169.1; -; mRNA.
EMBL; AC022150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC021101; AAH21101.1; -; mRNA.
EMBL; AF104254; AAD12723.1; -; mRNA.
CCDS; CCDS8295.1; -. [Q9NVC6-1]
RefSeq; NP_004259.3; NM_004268.4. [Q9NVC6-1]
UniGene; Hs.444931; -.
ProteinModelPortal; Q9NVC6; -.
SMR; Q9NVC6; -.
BioGrid; 114830; 85.
ComplexPortal; CPX-3227; Core mediator complex.
CORUM; Q9NVC6; -.
DIP; DIP-31451N; -.
IntAct; Q9NVC6; 42.
MINT; Q9NVC6; -.
STRING; 9606.ENSP00000251871; -.
iPTMnet; Q9NVC6; -.
PhosphoSitePlus; Q9NVC6; -.
BioMuta; MED17; -.
DMDM; 296437366; -.
EPD; Q9NVC6; -.
MaxQB; Q9NVC6; -.
PaxDb; Q9NVC6; -.
PeptideAtlas; Q9NVC6; -.
PRIDE; Q9NVC6; -.
ProteomicsDB; 82777; -.
ProteomicsDB; 82778; -. [Q9NVC6-2]
Ensembl; ENST00000251871; ENSP00000251871; ENSG00000042429. [Q9NVC6-1]
GeneID; 9440; -.
KEGG; hsa:9440; -.
UCSC; uc001pel.3; human. [Q9NVC6-1]
CTD; 9440; -.
DisGeNET; 9440; -.
EuPathDB; HostDB:ENSG00000042429.10; -.
GeneCards; MED17; -.
H-InvDB; HIX0010027; -.
HGNC; HGNC:2375; MED17.
HPA; HPA064236; -.
MalaCards; MED17; -.
MIM; 603810; gene.
MIM; 613668; phenotype.
neXtProt; NX_Q9NVC6; -.
OpenTargets; ENSG00000042429; -.
Orphanet; 402364; Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly.
PharmGKB; PA162395443; -.
eggNOG; KOG4512; Eukaryota.
eggNOG; ENOG410XRQ8; LUCA.
GeneTree; ENSGT00390000011810; -.
HOGENOM; HOG000008073; -.
HOVERGEN; HBG103247; -.
InParanoid; Q9NVC6; -.
KO; K15133; -.
OMA; PHHGTFE; -.
OrthoDB; EOG091G03JX; -.
PhylomeDB; Q9NVC6; -.
TreeFam; TF323615; -.
Reactome; R-HSA-1989781; PPARA activates gene expression.
Reactome; R-HSA-212436; Generic Transcription Pathway.
Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
ChiTaRS; MED17; human.
GeneWiki; MED17; -.
GenomeRNAi; 9440; -.
PRO; PR:Q9NVC6; -.
Proteomes; UP000005640; Chromosome 11.
Bgee; ENSG00000042429; -.
CleanEx; HS_MED17; -.
ExpressionAtlas; Q9NVC6; baseline and differential.
Genevisible; Q9NVC6; HS.
GO; GO:0016592; C:mediator complex; IDA:UniProtKB.
GO; GO:0016020; C:membrane; HDA:UniProtKB.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0005667; C:transcription factor complex; IDA:MGI.
GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB.
GO; GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB.
GO; GO:0038023; F:signaling receptor activity; IDA:UniProtKB.
GO; GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB.
GO; GO:0003713; F:transcription coactivator activity; IDA:MGI.
GO; GO:0003712; F:transcription cofactor activity; IDA:UniProtKB.
GO; GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB.
GO; GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB.
GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:MGI.
GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB.
InterPro; IPR019313; Mediator_Med17.
PANTHER; PTHR13114; PTHR13114; 1.
Pfam; PF10156; Med17; 1.
1: Evidence at protein level;
Activator; Alternative splicing; Complete proteome;
Direct protein sequencing; Disease mutation; Nucleus; Polymorphism;
Reference proteome; Transcription; Transcription regulation.
CHAIN 1 651 Mediator of RNA polymerase II
transcription subunit 17.
/FTId=PRO_0000079359.
VAR_SEQ 140 145 NPQTLQ -> VFVDFN (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_028115.
VAR_SEQ 146 651 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_028116.
VARIANT 69 69 E -> D (in dbSNP:rs2848477).
{ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:19369195,
ECO:0000269|PubMed:10198638,
ECO:0000269|PubMed:10235266,
ECO:0000269|PubMed:14702039,
ECO:0000269|PubMed:15489334}.
/FTId=VAR_063126.
VARIANT 357 357 F -> L (in dbSNP:rs35313315).
/FTId=VAR_057781.
VARIANT 371 371 L -> P (in MCPHSBA; dbSNP:rs267607232).
{ECO:0000269|PubMed:20950787}.
/FTId=VAR_065066.
CONFLICT 21 21 E -> G (in Ref. 3; BAB13973).
{ECO:0000305}.
CONFLICT 58 58 E -> G (in Ref. 3; BAB13973).
{ECO:0000305}.
CONFLICT 356 356 K -> N (in Ref. 2; AAD30856).
{ECO:0000305}.
CONFLICT 409 409 G -> Q (in Ref. 1; AA sequence).
{ECO:0000305}.
CONFLICT 531 531 Q -> H (in Ref. 6; AAD12723).
{ECO:0000305}.
SEQUENCE 651 AA; 72890 MW; 47011210952D287B CRC64;
MSGVRAVRIS IESACEKQVH EVGLDGTETY LPPLSMSQNL ARLAQRIDFS QGSGSEEEEA
AGTEGDAQEW PGAGSSADQD DEEGVVKFQP SLWPWDSVRN NLRSALTEMC VLYDVLSIVR
DKKFMTLDPV SQDALPPKQN PQTLQLISKK KSLAGAAQIL LKGAERLTKS VTENQENKLQ
RDFNSELLRL RQHWKLRKVG DKILGDLSYR SAGSLFPHHG TFEVIKNTDL DLDKKIPEDY
CPLDVQIPSD LEGSAYIKVS IQKQAPDIGD LGTVNLFKRP LPKSKPGSPH WQTKLEAAQN
VLLCKEIFAQ LSREAVQIKS QVPHIVVKNQ IISQPFPSLQ LSISLCHSSN DKKSQKFATE
KQCPEDHLYV LEHNLHLLIR EFHKQTLSSI MMPHPASAPF GHKRMRLSGP QAFDKNEINS
LQSSEGLLEK IIKQAKHIFL RSRAAATIDS LASRIEDPQI QAHWSNINDV YESSVKVLIT
SQGYEQICKS IQLQLNIGVE QIRVVHRDGR VITLSYQEQE LQDFLLSQMS QHQVHAVQQL
AKVMGWQVLS FSNHVGLGPI ESIGNASAIT VASPSGDYAI SVRNGPESGS KIMVQFPRNQ
CKDLPKSDVL QDNKWSHLRG PFKEVQWNKM EGRNFVYKME LLMSALSPCL L


Related products :

Catalog number Product name Quantity
10-288-22393F Cofactor required for Sp1 transcriptional activation subunit 9 - Transcriptional coactivator CRSP33; RNA polymerase transcriptional regulation mediator subunit 7 homolog; hMED7; Activator-recruited co 0.1 mg
10-288-22393F Cofactor required for Sp1 transcriptional activation subunit 9 - Transcriptional coactivator CRSP33; RNA polymerase transcriptional regulation mediator subunit 7 homolog; hMED7; Activator-recruited co 0.05 mg
18-003-43107 Cofactor required for Sp1 transcriptional activation subunit 9 - Transcriptional coactivator CRSP33; RNA polymerase transcriptional regulation mediator subunit 7 homolog; hMED7; Activator-recruited co 0.05 mg Aff Pur
18-003-43214 CRSP complex subunit 8 - Cofactor required for Sp1 transcriptional activation subunit 8; Transcriptional coactivator CRSP34; P37 TRAP_SMCC_PC2 subunit Polyclonal 0.1 mg Protein A
28-735 MED21 belongs to the Mediator complex subunit 21 family. It is the component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent ge 0.05 mg
10-288-22355F RNA polymerase transcriptional regulation mediator. subunit 6 homolog - Activator-recruited cofactor 33 kDa component; ARC33; NY-REN-28 antigen 0.1 mg
10-288-22355F RNA polymerase transcriptional regulation mediator. subunit 6 homolog - Activator-recruited cofactor 33 kDa component; ARC33; NY-REN-28 antigen 0.05 mg
27-934 CRSP9 is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. CRSP9 is also a component of other multisubunit com 0.05 mg
18-003-42176 Thyroid hormone receptor-associated protein complex 95 kDa component - Trap95; Thyroid hormone receptor-associated protein 5; Vitamin D3 receptor-interacting protein complex component DRIP92 Polyclona 0.1 mg Protein A
EIAAB08492 COG complex subunit 1,Cog1,Component of oligomeric Golgi complex 1,Conserved oligomeric Golgi complex subunit 1,Ldlb,Low density lipoprotein receptor defect B-complementing protein,Mouse,Mus musculus
EIAAB08495 COG complex subunit 2,Cog2,Component of oligomeric Golgi complex 2,Conserved oligomeric Golgi complex subunit 2,Ldlc,Low density lipoprotein receptor defect C-complementing protein,Mouse,Mus musculus
EIAAB08494 COG complex subunit 2,COG2,Component of oligomeric Golgi complex 2,Conserved oligomeric Golgi complex subunit 2,Homo sapiens,Human,LDLC,Low density lipoprotein receptor defect C-complementing protein
20-372-60194 cofactor required for Sp1 transcriptional activation. subunit 2. 150kDa (CRSP2) - Mouse monoclonal anti-human CRSP2 antibody; Cofactor required for Sp1 transcriptional activation subunit 2; Transcript 0.1 mg
20-372-60196 cofactor required for Sp1 transcriptional activation. subunit 7. 70kDa (CRSP7) - Mouse monoclonal anti-human CRSP7 antibody; Cofactor required for Sp1 transcriptional activation subunit 7; Transcripti 0.1 mg
25-191 MED6 is a component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information 0.05 mg
EIAAB08503 13S Golgi transport complex 90 kDa subunit,Bos taurus,Bovine,COG complex subunit 5,COG5,Component of oligomeric Golgi complex 5,Conserved oligomeric Golgi complex subunit 5,GTC-90
EIAAB08496 COG complex subunit 3,COG3,Component of oligomeric Golgi complex 3,Conserved oligomeric Golgi complex subunit 3,Homo sapiens,Human,p94,SEC34,Vesicle-docking protein SEC34 homolog
EIAAB08501 13S Golgi transport complex 90 kDa subunit,COG complex subunit 5,COG5,Component of oligomeric Golgi complex 5,Conserved oligomeric Golgi complex subunit 5,Golgi transport complex 1,GOLTC1,GTC90,GTC-90
EIAAB06531 Cdk8,Cell division protein kinase 8,Cyclin-dependent kinase 8,Mediator complex subunit CDK8,Mediator of RNA polymerase II transcription subunit CDK8,Mouse,Mus musculus
EIAAB33312 Complex III subunit 8,Complex III subunit VIII,Cytochrome b-c1 complex subunit 8,Low molecular mass ubiquinone-binding protein,Qpc,Rat,Rattus norvegicus,Ubiquinol-cytochrome c reductase complex 9.5 kD
EIAAB08493 COG complex subunit 1,COG1,Component of oligomeric Golgi complex 1,Conserved oligomeric Golgi complex subunit 1,Homo sapiens,Human,KIAA1381,LDLB
27-157 USP22 is a subunit of the SAGA transcriptional cofactor complex. It deubiquitylates histone H2B and is recruited to specific genes by activators like Myc. USP22 is needed for cell cycle progression. I 0.05 mg
EIAAB08512 COG complex subunit 8,Cog8,Component of oligomeric Golgi complex 8,Conserved oligomeric Golgi complex subunit 8,MNCb-5704,Mouse,Mus musculus
EIAAB08505 COG complex subunit 6,COG6,Component of oligomeric Golgi complex 6,Conserved oligomeric Golgi complex subunit 6,Homo sapiens,Human,KIAA1134
EIAAB08509 COG complex subunit 7,COG7,Component of oligomeric Golgi complex 7,Conserved oligomeric Golgi complex subunit 7,Homo sapiens,Human,UNQ3082_PRO10013


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur